Ex-Valeant Executive Guilty of Taking Pharmacy CEO’s Bribe

  • Three-week trial in N.Y. revived the drugmaker’s past pain
  • Jurors were told of an alias emails and offshore accounts
Valeant Pharmaceuticals International Inc. headquarters stands in Bridgewater Township, New Jersey.

Photographer: Michael Nagle/Bloomberg

Lock
This article is for subscribers only.

Former Valeant Pharmaceuticals International Inc. executive Gary Tanner was found guilty of accepting a $10 million bribe for manipulating the company’s takeover of a startup mail-order pharmacy in 2014.

Ex-Philidor Rx Services LLC Chief Executive Officer Andrew Davenport, who paid the kickback, was also convicted Tuesday after a three-week trial. The jury verdict in Manhattan federal court is the latest fallout from a scandal that shook the drugmaker three years ago.